103 related articles for article (PubMed ID: 23639452)
1. Cell-penetrating cationic siRNA and lipophilic derivatives efficient at nanomolar concentrations in the presence of serum and albumin.
Perche P; Nothisen M; Bagilet J; Behr JP; Kotera M; Remy JS
J Control Release; 2013 Aug; 170(1):92-8. PubMed ID: 23639452
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications.
O'Mahony AM; Doyle D; Darcy R; Cryan JF; O'Driscoll CM
Eur J Pharm Sci; 2012 Dec; 47(5):896-903. PubMed ID: 23022516
[TBL] [Abstract][Full Text] [Related]
3. Structure Tuning of Cationic Oligospermine-siRNA Conjugates for Carrier-Free Gene Silencing.
Nothisen M; Bagilet J; Behr JP; Remy JS; Kotera M
Mol Pharm; 2016 Aug; 13(8):2718-28. PubMed ID: 27398779
[TBL] [Abstract][Full Text] [Related]
4. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.
Baoum A; Ovcharenko D; Berkland C
Int J Pharm; 2012 May; 427(1):134-42. PubMed ID: 21856394
[TBL] [Abstract][Full Text] [Related]
5. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
6. Conjugating phosphospermines to siRNAs for improved stability in serum, intracellular delivery and RNAi-mediated gene silencing.
Paris C; Moreau V; Deglane G; Karim L; Couturier B; Bonnet ME; Kedinger V; Messmer M; Bolcato-Bellemin AL; Behr JP; Erbacher P; Lenne-Samuel N
Mol Pharm; 2012 Dec; 9(12):3464-75. PubMed ID: 23148419
[TBL] [Abstract][Full Text] [Related]
7. siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine.
Hattori Y; Nakamura T; Ohno H; Fujii N; Maitani Y
Int J Pharm; 2013 Feb; 443(1-2):221-9. PubMed ID: 23279939
[TBL] [Abstract][Full Text] [Related]
8. Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.
Tagalakis AD; He L; Saraiva L; Gustafsson KT; Hart SL
Biomaterials; 2011 Sep; 32(26):6302-15. PubMed ID: 21624650
[TBL] [Abstract][Full Text] [Related]
9. Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy.
Buyens K; Meyer M; Wagner E; Demeester J; De Smedt SC; Sanders NN
J Control Release; 2010 Jan; 141(1):38-41. PubMed ID: 19737587
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
11. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic polyallylamine based polymeric micelles for siRNA delivery to the gastrointestinal tract: in vitro investigations.
Guo J; O'Mahony AM; Cheng WP; O'Driscoll CM
Int J Pharm; 2013 Apr; 447(1-2):150-7. PubMed ID: 23467082
[TBL] [Abstract][Full Text] [Related]
13. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
[TBL] [Abstract][Full Text] [Related]
14. Cationic siRNAs provide carrier-free gene silencing in animal cells.
Nothisen M; Kotera M; Voirin E; Remy JS; Behr JP
J Am Chem Soc; 2009 Dec; 131(49):17730-1. PubMed ID: 19928854
[TBL] [Abstract][Full Text] [Related]
15. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA nunchucks with a hydrophobic linker for efficient intracellular delivery.
Jo SD; Kim JS; Joe CO; Mok H; Nam YS
Macromol Biosci; 2014 Feb; 14(2):195-201. PubMed ID: 24106091
[TBL] [Abstract][Full Text] [Related]
17. Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound.
Negishi Y; Endo Y; Fukuyama T; Suzuki R; Takizawa T; Omata D; Maruyama K; Aramaki Y
J Control Release; 2008 Dec; 132(2):124-30. PubMed ID: 18804499
[TBL] [Abstract][Full Text] [Related]
18. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.
Han SE; Kang H; Shim GY; Suh MS; Kim SJ; Kim JS; Oh YK
Int J Pharm; 2008 Apr; 353(1-2):260-9. PubMed ID: 18178348
[TBL] [Abstract][Full Text] [Related]
19. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
Xiong XB; Uludağ H; Lavasanifar A
Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
